• How are Labelling Software Solutions Helping Medical Device and Life Science Organisations Prepare for the Future?
    Richard Adams, Chief Executive Officer, PRISYM ID.

Laboratory Products

How are Labelling Software Solutions Helping Medical Device and Life Science Organisations Prepare for the Future?

Jun 17 2021

Why are label management solutions important to medical device and life science organisations?

Global label management solutions are of paramount importance to medical device and life science organisations as they help to reduce regulatory risk. Labels contain a wide range of content, such as instructions for use, batch numbers, expiry dates and safety precautions. All of this information is vital to ensure their safe and effective use by health professionals and patients.

Is the demand for regulated labelling software systems increasing?

PRISYM ID announced five important business wins at the start of the year, and has recently successfully implemented a further six new regulated labelling software systems as demand from across the medical device and life science sectors increases.

The market leading labelling software firm says that this achievement shows the medical device and life science industries are recovering from the COVID-19 pandemic impact and are refocusing on installing labelling management solutions to help prepare for the future.

Customers are looking for solutions that will increase their flexibility and allow them to respond more effectively to any change or uncertainty in their business over the months ahead after the pandemic experience.

Many organisations are prioritising speed of implementation as they seek to implement solutions that can help them as they prepare for life post pandemic - as a result, PRISYM ID says that its customers are putting a far greater focus on so-called ‘time to value’ for their technology investments than ever before.

Richard Adams, Chief Executive of PRISYM ID, said: “We are incredibly pleased to have delivered PRISYM 360 solutions across both our medical device and clinical trial supply sectors. The first few months of 2021 have been extremely busy for us as it is clear that the legacy of COVID-19 has focused people’s minds.

“For our customers, fast and agile implementation combined with specialist industry knowledge are extremely important, and the projects we have successfully executed in recent months show we can deliver the best of all worlds: high quality solutions, delivered at speed, by genuine experts in the field.”

More information online

Digital Edition

LabAsia Buyers Guide 2021

October 2021

In this Edition Articles - Applications of Newly Developed 2.7 μm Porous Graphitic Carbon Particles in U/HPLC - Improve sensitivity and decrease matrix effects in pesticide residue analysis...

View all digital editions


ASMS Conference - NEW DATES

Oct 31 2021 Philadelphia, PA, USA

analytica Lab Africa -CANCELLED

Nov 02 2021 Johannesburg, South Africa

Lab Innovations 2021

Nov 03 2021 Birmingham, UK

ISPPP 2021

Nov 07 2021 Porto, Portugal

JASIS 2021

Nov 08 2021 Chiba, Japan

View all events